Article
Document
Anualidad
Academic Article
Information Content Entity
Continuant
Entity
Generically Dependent Continuant
Effect of glycoprotein IIb/IIIa receptor blocker abcximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the Gusto IV-ACS randomised trial.
RDF description of Effect of glycoprotein IIb/IIIa receptor blocker abcximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the Gusto IV-ACS randomised trial. - http://research.umh.es/vivo/pub/articulo/5584